Delivery Order SPE2DB20D2014-SPE2DB26FA14P
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,675.92 for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This contract, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, was competitively awarded without set-aside designation under a firm fixed price structure. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,465.19 to AmerisourceBergen Drug Corp for the supply of ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.74 to AmerisourceBergen Drug Corp for ADDYI (flibansergin) 100 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing work at its corporate office location. This delivery order is issued under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,174.04 to AmerisourceBergen Drug Corp for supply of ADDYI (flibanserins) 100 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 9, 2025, and was awarded on May 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,102.82 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (flibanserin), a prescription medication, valued at $1,935.74 under a firm fixed-price contract awarded on April 23, 2025, with an ultimate completion date of April 24, 2025. The delivery location is the company's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, demonstrating AmerisourceBergen's continued capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserene) 100 mg tablets in quantities of 30 units, with a ceiling value of $41,739.01. This firm fixed price delivery order, awarded September 4, 2025, with ultimate completion by September 5, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $5,959.27 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of ADDYI (flibansergin) 100 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for ultimate completion on September 8, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $9,497.18 to AmerisourceBergen Drug Corp for ADDYI (flibansererin) 100 mg tablets in packages of 30 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 3, 2025. The contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of ADDYI (flibanserrin) 100 mg tablets in quantities of 30 units, with a contract ceiling value of $2,030.63. This is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and represents a competitive award with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA14PDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,046.12 to AmerisourceBergen Drug Corp for 30-count units of ADDYI (flibanserine) 100 mg tablets. This delivery order, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, represents a firm fixed price procurement with no set-aside designation. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive pharmaceutical and medical supply portfolio includes brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order exemplifies the company's role within the DLA's pharmaceutical supply chain, supporting Defense Health Agency and other federal healthcare system requirements through the broader global pharmaceutical support vehicle that enables flexible procurement of medical commodities to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 10/21/25 |